BioXcel Therapeutics, Inc. (BTAI)
NASDAQ: BTAI · Real-Time Price · USD
1.205
-0.015 (-1.23%)
May 11, 2026, 3:23 PM EDT - Market open
BioXcel Therapeutics Market Cap
BioXcel Therapeutics has a market cap or net worth of $32.62 million as of May 11, 2026. Its market cap has increased by 223.02% in one year.
Market Cap
32.62M
Enterprise Value
114.27M
1-Year Change
223.02%
Ranking
Category
Stock Price
$1.21
Market Cap Chart
Since March 8, 2018, BioXcel Therapeutics's market cap has decreased from $167.60M to $32.62M, a decrease of -80.53%. That is a compound annual growth rate of -18.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 33.00M | -5.71% |
| Dec 31, 2025 | 35.00M | 118.75% |
| Dec 31, 2024 | 16.00M | -81.48% |
| Dec 29, 2023 | 86.40M | -85.65% |
| Dec 30, 2022 | 601.90M | 5.82% |
| Dec 31, 2021 | 568.80M | -49.48% |
| Dec 31, 2020 | 1.13B | 327.25% |
| Dec 31, 2019 | 263.50M | 336.26% |
| Dec 31, 2018 | 60.40M | -63.96% |
| Mar 8, 2018 | 167.60M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cumberland Pharmaceuticals | 70.00M |
| Incannex Healthcare | 64.00M |
| BGM Group | 53.90M |
| InterCure | 47.53M |
| Talphera | 46.90M |
| Zhengye Biotechnology Holding | 45.00M |
| Rockwell Medical | 32.86M |
| Aytu BioPharma | 26.83M |